文献速递神经肿瘤

偶发脑膜瘤的发病率、管理与结局:10年间发生了什么变化

Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?
PubMed 文献 · J Neurooncol · 2023-11-08

该回顾性研究分析两个时间段内全部脑部CT和MRI检查,寻找 presumed 偶发脑膜瘤患者,并随访3年。两时间段接受脑影像的独立患者数相同(22259 vs 22013),2018-2019年偶发脑膜瘤诊断数较2008-2009年增加25%(161 vs 129,p=0.052),MRI使用更多、增强扫描更多、患者更老;诊断时管理决策无显著差异,但3年内再次扫描显著增多,近三分之一患者3年内死于脑膜瘤以外原因。

要点

  • 2018-2019年偶发脑膜瘤诊断数较2008-2009年增加25%(161 vs 129,p=0.052),呈趋势性增多。
  • 2018-2019年MRI使用比例26.1% vs 12.4%(p=0.004),增强扫描比例26.8% vs 12.2%(p<0.001)。
  • 两个队列分别有29.5%和35.4%的患者在诊断后3年内死于与脑膜瘤无关的原因。

核心结论

  • 尽管两个时间段接受脑扫描的独立患者数相同,近年诊断的偶发无症状脑膜瘤患者呈增多趋势,可能归因于更多增强扫描和更多老年人接受扫描,但需进一步研究。

研究设计与样本

  • 回顾性研究,审查两个时间段内所有进行的脑部CT和MRI检查,以寻找 presumed 偶发脑膜瘤患者,并利用医疗健康记录分析其临床处理及3年随访结局。

主要发现

  • 两个时间段接受脑影像的独立患者数相同(n=22259 vs n=22013)。
  • 2018-2019年诊断的偶发脑膜瘤较2008-2009年增加25%(n=161 vs n=129,p=0.052)。
  • 2018-2019年MRI使用更多(26.1% vs 12.4%,p=0.004),增强扫描使用(不论模态)也增加(26.8% vs 12.2%,p<0.001)。
  • 最近队列患者年龄更大(中位79岁 vs 73岁,p=0.03)。
  • 扫描患者中,无已知转移的癌症作为扫描指征显著增加。

临床怎么用

  • 诊断时管理决策无显著差异,但3年随访内后一队列显著更多患者接受了再次扫描。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to study the use of brain scanning, and the subsequent findings of presumed incidental meningioma in two time periods, and to study differences in follow-up, treatment, and outcome. METHODS: Records of all performed CT and MRI of the brain during two time periods were retrospectively reviewed in search of patients with presumed incidental meningioma. These patients were further analyzed using medical health records, with the purpose to study clinical handling and outcome during a 3 year follow up. RESULTS: An identical number of unique patients underwent brain imaging during the two time periods (n = 22 259 vs. 22 013). In 2018-2019, 25% more incidental meningiomas were diagnosed compared to 2008-2009 (n = 161 vs. 129, p = 0.052). MRI was used more often in 2018-2019 (26.1 vs. 12.4%, p = 0.004), and the use of contrast enhancement, irrespective of modality, also increased (26.8 vs. 12.2%, p < 0.001). In the most recent cohort, patients were older (median 79 years vs. 73 years, p = 0.03). Indications showed a significant increase of cancer without known metastases among scanned patients. 29.5 and 35.4% of patients in the cohorts were deceased 3 years after diagnosis for causes unrelated to their meningioma. CONCLUSIONS: Despite the same number of unique patients undergoing brain scans in the time periods, there was a trend towards more patients diagnosed with an incidental asymptomatic meningioma in the more recent years. This difference may be attributed to more contrast enhanced scans and more scans among the elderly but needs to be further studied. Patients in the cohort from 2018 to 2019 more often had non-metastatic cancer, with their cause of scan screening for metastases. There was no significant difference in management decision at diagnosis, but within 3 years of follow up significantly more patients in the latter cohort had been re-scanned. Almost a third of all patients were deceased within 3 years after diagnosis, due to causes other than their meningioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Näslund O, Strand PS, Solheim O, et al. Incidence, management, and outcome of incidental meningioma: what has happened in 10 years? J Neurooncol. 2023. PMID: 37938444. doi:10.1007/s11060-023-04482-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。